Strategic Wealth Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.9K Buy
168
+5
+3% +$1.04K ﹤0.01% 574
2026
Q1
$34.3K Buy
163
+1
+0.6% +$215 ﹤0.01% 592
2025
Q4
$33.3K Buy
162
+22
+16% +$4.14K ﹤0.01% 593
2025
Q3
$22K Hold
140
﹤0.01% 709
2025
Q2
$23.5K Buy
+140
New +$20.8K ﹤0.01% 622
2019
Q4
Sell
-137
Closed -$6 182
2019
Q3
$6 Sell
137
-347
-72% -$15.8K ﹤0.01% 619
2019
Q2
$22K Buy
484
+158
+48% +$7.29K 0.01% 318
2019
Q1
$16K Sell
326
-204
-38% -$10.2K 0.01% 402
2018
Q4
$25K Sell
530
-236
-31% -$12.3K 0.01% 304
2018
Q3
$41K Sell
766
-235
-23% -$12K 0.02% 242
2018
Q2
$49K Sell
1,001
-414
-29% -$23.5K 0.03% 259
2018
Q1
$89K Sell
1,415
-8,993
-86% -$617K 0.05% 205
2017
Q4
$631K Buy
+10,408
New +$643K 0.35% 98

Other funds holding CAH

Strategic Wealth Partners's CAH Position: Q2 2026 in Review

Strategic Wealth Partners increased its Cardinal Health (CAH) stake by 3.1% in Q2 2026, buying an estimated $1.04K and bringing the position to 168 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Strategic Wealth Partners first reported a position in CAH in Q4 2017 and has held it in 13 quarters since. The position peaked at $631K in Q4 2017. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Strategic Wealth Partners held 168 shares of Cardinal Health worth $39.9K as of Q2 2026.
  • Strategic Wealth Partners bought 5 Cardinal Health shares in Q2 2026, an estimated $1.04K.
  • Cardinal Health made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #574 holding.
  • Strategic Wealth Partners first reported a position in Cardinal Health in Q4 2017 and has held it in 13 quarters since.
  • Strategic Wealth Partners's Cardinal Health position peaked at $631K in Q4 2017.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.